Articles with public access mandates - Arie PerryLearn more
Not available anywhere: 11
Review
Neurofibromatosis type 1
DH Gutmann, RE Ferner, RH Listernick, BR Korf, PL Wolters, KJ Johnson
Nature Reviews Disease Primers 3 (1), 1-17, 2017
Mandates: US Department of Defense
Review
Mucoepidermoid carcinoma of the cervix: another tumor with the t (11; 19)-associated CRTC1-MAML2 gene fusion
JKM Lennerz, A Perry, JC Mills, PC Huettner, JD Pfeifer
The American journal of surgical pathology 33 (6), 835-843, 2009
Mandates: US National Institutes of Health
Review
Sellar region atypical teratoid/rhabdoid tumors (ATRT) in adults display DNA methylation profiles of the ATRT-MYC subgroup
PD Johann, S Bens, F Oyen, R Wagener, C Giannini, A Perry, ...
The American Journal of Surgical Pathology 42 (4), 506-511, 2018
Mandates: Helmholtz Association
Review
Salvage therapy outcomes for atypical meningioma
WC Chen, J Hara, ST Magill, A Wu, MK Aghi, PV Theodosopoulos, ...
Journal of neuro-oncology 138, 425-433, 2018
Mandates: US National Institutes of Health
Review
Intracranial subdural osteoma: a rare benign tumor that can be differentiated from other calcified intracranial lesions utilizing MR imaging
RF Barajas Jr, A Perry, M Sughrue, M Aghi, S Cha
Journal of Neuroradiology 39 (4), 263-266, 2012
Mandates: US National Institutes of Health
Review
Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker
M Pekmezci, JJ Phillips, F Dirilenoglu, T Atasever-Rezanko, T Tihan, ...
Acta Neuropathologica 139, 597-600, 2020
Mandates: US National Institutes of Health
Review
A review of recently described genetic alterations in central nervous system tumors
CHG Lucas, DA Solomon, A Perry
Human pathology 96, 56-66, 2020
Mandates: US National Institutes of Health
Review
Ctni-57. low-risk meningioma: outcomes from Nrg Oncology/Rtog 0539
L Rogers, S Pugh, M Vogelbaum, A Perry, L Ashby, J Modi, A Alleman, ...
Neuro-oncology 22 (Supplement_2), ii55-ii56, 2020
Mandates: US National Institutes of Health
Review
Eye-sparing treatment of localized orbital medulloepithelioma with neoadjuvant chemoradiation
RA Gallo, J Shoag, TE Johnson, DA Solomon, A Perry, A Podda, JY Lee, ...
Ophthalmic Plastic & Reconstructive Surgery 37 (1), e13-e16, 2021
Mandates: US National Institutes of Health
Review
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the …
S Mueller, J Fangusaro, AO Thomas, TS Jacques, P Bandopadhayay, ...
Neuro-oncology 26 (3), 407-416, 2024
Mandates: Brain Tumour Charity, UK
Review
Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas
J Wang, J Ma
Journal of Neurological Surgery Part A: Central European Neurosurgery 80 (04 …, 2019
Mandates: National Natural Science Foundation of China
Available somewhere: 161
Review
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131, 803-820, 2016
Mandates: Helmholtz Association
Review
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
Mandates: US National Institutes of Health, Helmholtz Association, Cancer Research UK …
Review
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
JE Eckel-Passow, DH Lachance, AM Molinaro, KM Walsh, PA Decker, ...
New England Journal of Medicine 372 (26), 2499-2508, 2015
Mandates: US National Institutes of Health
Review
New brain tumor entities emerge from molecular classification of CNS-PNETs
D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ...
Cell 164 (5), 1060-1072, 2016
Mandates: US National Institutes of Health, Helmholtz Association, Cancer Research UK …
Review
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition
M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ...
Cancer cell 25 (3), 393-405, 2014
Mandates: US National Institutes of Health, Dutch Cancer Society
Review
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
DJ Brat, K Aldape, H Colman, EC Holland, DN Louis, RB Jenkins, ...
Acta neuropathologica 136, 805-810, 2018
Mandates: US National Institutes of Health
Review
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems
FJ Rodriguez, AL Folpe, C Giannini, A Perry
Acta neuropathologica 123, 295-319, 2012
Mandates: US National Institutes of Health
Review
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ...
Acta neuropathologica 121, 381-396, 2011
Mandates: US National Institutes of Health
Review
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ...
Neuro-oncology 18 (4), 557-564, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program